VA plans to fund clinical trials of psychedelic-assisted therapies using magic mushrooms and ecstasy to treat PTSD.

February 15, 2024 - Reading time: 3 minutes

The U.S. Food and Drug Administration (FDA) has agreed to review a new drug application for MDMA, commonly known as ecstasy, to be developed for the treatment of post-traumatic stress disorder (PTSD) in a supervised clinical setting.

Over 500 Deaths Linked to Recalled Philips Breathing Devices, FDA Reports

February 2, 2024 - Reading time: 2 minutes

The U.S. Food and Drug Administration (FDA) has announced that it has received reports of 561 deaths associated with Philips respiratory devices designed for the treatment of obstructive sleep apnea and other respiratory disorders.